发明名称 Targeted delivery of therapeutic and diagnostic moieties
摘要 Compositions and methods for improving cellular internalization of one or more compounds are disclosed. The invention provides a drug conjugate composition that can be delivered to a target cell, which comprises a carrier compound that has a binding specificity for a receptor molecule and is conjugated to a therapeutic or diagnostic moiety. When this composition is administered to a subject, the carrier compound binds to the receptor and is internalized by the target cell. Furthermore, monoclonal antibodies are disclosed that are internalized into target cells. The monoclonal antibodies of the invention are specific for target cells, particularly for cells expressing the surface antigen p185HER-2. The antibodies of the invention may be conjugated with a molecule for delivery into a target cell. Such molecules may be used for therapeutic treatment, including gene therapy, and for imaging. The invention also provides DNA sequences of the variable regions of particular monoclonal antibodies.
申请公布号 AU1490801(A) 申请公布日期 2001.05.30
申请号 AU20010014908 申请日期 2000.11.15
申请人 UNIVERSITY OF SOUTHERN CALIFORNIA 发明人 MICHAEL PRESS;JINHA PARK
分类号 G01N33/574;A61K39/395;A61K47/42;A61K47/48;A61K49/00;A61K49/16;A61K51/10;A61P9/10;A61P17/06;A61P25/00;A61P27/02;A61P35/00;C07K16/28;C07K16/32;C12N15/09;G01N33/577;(IPC1-7):A61K47/48 主分类号 G01N33/574
代理机构 代理人
主权项
地址